Mitesco (MITI) Short-Term Debt issuances (2021)
Mitesco (MITI) reported Short-Term Debt issuances of -$1834.0 for Q4 2021, up 98.97% on a QoQ basis from -$177534.0 in Q1 2021.
Mitesco (MITI) has 1 years of Short-Term Debt issuances data on file, last reported at -$1834.0 in Q4 2021.
- Quarterly Short-Term Debt issuances changed N/A year-over-year to -$1834.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was -$1834.0 (changed N/A YoY) and the FY2021 annual result came in at -$179368.0, changed N/A from the prior year.
- Short-Term Debt issuances advanced to -$1834.0 in Q4 2021 per MITI's latest filing, from -$177534.0 in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at -$1834.0 in Q4 2021 and bottomed at -$177534.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Mitesco | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1,834.00 |
| Dec 31, 2021 | -1,834.00 |
| Mar 31, 2021 | -177,534.00 |
| Mar 31, 2021 | -177,534.00 |